Modelling the carbon footprint of reflux control

International Journal of Surgery

Volumn 9, Issue 1, 2011, Pages 72-74

  Gatenby, Piers A C ^a,b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c Department of Health ^*  (United Kingdom)

Author keywords

Antreflux surgery; Carbon footprint; PPI; Proton pump inhibitor; Sustainability

Indexed keywords

CARBON DIOXIDE; PROTON PUMP INHIBITOR;

ADULT; ANTIREFLUX OPERATION; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CARBON FOOTPRINT; DRUG COST; ESOPHAGUS MANOMETRY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SURGERY; GENERAL PRACTITIONER; HEALTH CARE COST; HOSPITAL CARE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MODEL; NATIONAL HEALTH SERVICE; OPERATION DURATION; OUTPATIENT CARE; PRIORITY JOURNAL; UNITED KINGDOM;

CARBON FOOTPRINT; CLINICAL PROTOCOLS; COSTS AND COST ANALYSIS; CRITICAL PATHWAYS; ENGLAND; GASTROESOPHAGEAL REFLUX; HUMANS; MODELS, BIOLOGICAL; STATE MEDICINE;

EID: 78651080863     PISSN: 17439191     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsu.2010.09.008     Document Type: Article

References (11)

1. Epstein D., Bojke L., Schulper M. The REFLUX trial group. Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study. BMJ 2009, 339:152-155.
2. Lundell L., Attwood S., Ell C., Fiocca R., Galmiche J., Hatlebakk J., et al. Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial. Gut 2008, 57(9):1207-1213.
3. Pencheon D., Cointet S., Brown J., Howley J., Tennison I., Greensmith H., et al. Saving carbon, improving health: NHS carbon reduction strategy for England 2009, Sustainable Development Unit, Cambridge, UK. http://www.sdu.nhs.uk/page.php%3Fpage_id%3D160.
4. Grant A., Wileman S., Ramsay C., Bojke L., Epstein D., Schulper M., et al. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trail. Health Technol Assess 2008, 12(31).
5. Scott K., Barrett J., Wiedmann T., Minx J. Carbon footprint of the National health Service in England 2008, Stockholm Environment Institute and Sustainable Development Unit, Cambridge, UK. http://www.sd-commission.org.uk/publications/downloads/NHS_Carbon_Emissions_modelling1.pdf.
6. The NHS Information Centre PSC Prescription cost analysis England 2009 2010, Health and Social Care Information Centre, Leeds, UK, Report No.: 1. http://www.ic.nhs.uk/webfiles/publications/prescostanalysis2009/PCA_2009.pdf.
7. Reimer C., Bytzer P. Clinical trial: long-term use of proton pump inhibitors in primary care patients - a cross sectional analysis of 901 patients. Aliment Pharmacol Ther 2009, 30(7):725-732.
8. Gatenby P., Bann S. Antireflux surgery. Minerva Chir 2009, 64(2):169-181.
9. The NHS Information Centre Total procedures and interventions, 2008-2009 2010, NHS Information Centre, Leeds, UK. http://www.ic.nhs.uk/statistics-and-data-collections/hospital-care/hospital-activity-hospital-episode-statistics%2013%3Bhes/hospital-episode-statistics-hes-admitted-patient-care-england-2008-09.
10. Office of National Statistics 2008-based period and cohort life expectancy tables 2009, Office for National Statistics, Newport, UK. http://www.statistics.gov.uk/downloads/theme_population/NPP2008/wUKcohort08.xls.
11. Stern N. Stern review: the economics of climate change 2006, webarchive.nationalarchives.gov.uk/+/, Cambridge University Press, Cambridge, UK. http://www.hm-treasury.gov.uk/sternreview_index.htm.